Potential Clinical Applications of Multi-functional Milk Proteins and Peptides in Cancer Management

ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)


Volume 23, 42 Issues, 2016


Download PDF Flyer




Current Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 10th of 59 in Chemistry & Medicinal
  • 63rd of 253 in Pharmacology & Pharmacy
  • 100th of 289 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.455
5 - Year: 3.792

Potential Clinical Applications of Multi-functional Milk Proteins and Peptides in Cancer Management



Current Medicinal Chemistry, 21(21): 2424-2437.

Author(s): H. YF Chen, O. Mollstedt, Men-Hwei Tsai and RB Kreider.

Affiliation: Ambryx Inc., 1200 Columbia Ave., Riverside, California, 92507, USA.

Abstract

The progression of cancer involves multiple changes that alter intracellular signaling to promote cell proliferation. Subsequent remodeling of the tumor microenvironment enhances metastasis by manipulating the immune system. Research in the past decade has shown that milk proteins and peptides are often multi-functional, exerting activities such as anti-microbial, immunomodulatory, cancer cell apoptosis, anti-metastasis, and antioxidant effects. Several milk-derived biologics, such as HAMLET (human α-lactalbumin made lethal to tumor cells) and the human recombinant form of lactoferrin, already demonstrated promising results in clinical trials. Lactoferricin peptide analogs are in early clinical development as antimicrobial agents and cancer immunotherapies. In addition, milk proteins and peptides are well tolerated and many exhibit oral bioavailability; thus they may complement standard therapies to boost overall success in cancer treatments. Lactoferrin, colostrum, and specific milk-derived peptide fractions are currently being developed as clinical nutrition for cancer prevention and chemotherapy protection. This review highlights the potential applications of milk proteins and peptides as pharmaceutical drug candidates and clinical nutrition in the overall management of cancer.

Keywords:

Apoptosis, cancer, clinical nutrition, immunomodulatory, milk, peptides, therapeutics.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 21
Issue Number: 21
First Page: 2424
Last Page: 2437
Page Count: 14
DOI: 10.2174/0929867321666140205135739
Price: $58
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science